Miguel Quijada‐Álamo

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

Maribel Forero‐Castro, Cristina Robledo, Rocí­o Benito et al. · British Journal of Cancer · 2017 · 51 citations · Full text

Medicine, Genetics, Hematology +17

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Cristina Robledo et al. · Journal of Hematology & Oncology · 2017 · 49 citations · Full text

Life Sciences, Genetics, Hematology +17

Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer

Meriem Belabed, Matthew D. Park, Cédric M. Blouin et al. · Nature Immunology · 2025 · 43 citations

Life Sciences, Cell Biology, Immunology +16

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of <i>BCR/ABL in vitro</i> and in a xenograft model of chronic myeloid leukemia

Ignacio García‐Tuñón, María Hernández‐Sánchez, José Luis Ordóñez et al. · Oncotarget · 2017 · 40 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +17

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Verónica Alonso-Pérez et al. · Leukemia · 2020 · 37 citations · Full text

Medicine, Genetics, Oncology +16